Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative biolabs has developed Lentiviral CAR vector pCDCAR1 CADM1 (PTA021_A1) h(28OX_), which is constructed for the engineering of T cells to target human CADM1. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-CADM1 antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of lung cancer and pancreatic cancer.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.